Abstract
The biological problem
Class 11 major histocompatibility complex (MHC) molecules play an essential role in the body's immune response to antigen invasion. Once an antigen-presenting cell (macrophage, dendritic cell or B lymphocyte) captures an extracellular antigen, the protein component of the antigen is degraded into peptide fragments. Class II MHC molecules in the cell's interior bind to some of these fragments, and the peptide/MHC complexes travel to the cell surface. Nearby CD4 T lymphocytes are stimulated when they bind to the peptide/MHC complex, thereby activating an immune response.
Class I and class II MHC molecules are similar in structure and function. The X-ray crystal structures of class I MHC molecules have been determined, and peptides bound to them have been characterized by direct sequencing (Falk et al., 1991; Jardetzky et al., 1991; Matsumura et al., 1992) . The class I MHC binding site is closed at both ends, accommodating a ligand of 8-9 residues. The primary structures of ligands reveal binding motifs relative to their N-and Ctermini.
The class II MHC binding site has been shown to bind ligands of 10-25 residues. It had been theorized that the binding site was open at one end (Rudensky et al., 1991) . California, San Francisco, Fresno, CA 93703, Now X-ray crystallography confirms that the binding site is open at both ends (Brown ef al., 1993; Stern etal., 1994) . This configuration makes binding motif determination much more difficult since the proper alignment must be established before a motif can be considered.
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Several researchers (O'Sullivan et al., 1991a; Chicz et al., 1992; Hammer et al., 1993; Falk et al., 1994) have tackled this problem and proposed motifs for class II MHC binding. In most cases, the motifs were not extensively tested on nonbinding peptides. It is the task of this research to develop a procedure that takes a suggested motif and converts it into a quantitative model that classifies both binders and nonbinders accurately. O'Sullivan et al. (1990) published a database that provides sets of binding and non-binding peptides for DR1, DR2, DR5 and DR52a haplotypes of class II MHC molecules. Three peptides studied in a subsequent report (O'Sullivan et al., 1991a) were added, for a total of 135 peptides. The example used to illustrate the algorithm investigates peptides which bind to the DR1 MHC haplotype. In the database there are 37 peptides that bind DR1 and 98 that do not. O'Sullivan et al. (1991b) suggest the following DR1 binding motif: W, F, Y, V, I or L in position 1; A, V, I, L, P, C, S or T in position 6; and A, V, I, L, C, S, T, M, or Y in position 9. Table I illustrates how this motif can be represented by a matrix of zeros and ones.
The database and initial motif
Let an element of a motif matrix be denoted by m m , and a sub-sequence of nine residues by ri^r^r^rgrc). A measure of how well such a sub-sequence fits a motif can then be defined as f(r|r 2 r3r4r 5 r 6 r 7 r 8 r9)= Yl'i= 9 \ m r,,-As an example, consider influenza virus hemagglutinin 306-318, PKYVKQNTLKLAT, which does bind DR1. f(PKYVKQNTL) = 1 since only the L in position 9 matches the motif. If all possible sub-sequences of length 9 are considered, f(YVKQNTLKL) = 3 and f(VKQNTLKLA) = 3 yield the highest f() values for this peptide. Sub-sequences such as these which yield maximal f() values will be referred to as maximal sub-sequences.
Stepwise discriminant analysis
Given a database with two mutually exclusive sets, stepwise discriminant analysis (SDA) (Dixon et al., 1990 ) builds a mathematical function which classifies each member of the database into one of the two sets. Arguments for the function are selected from a list of potential predictor variables in order of significance. An F-value determines order of significance, and a minimum value of F -4 is necessary for model entrance. The jackknife method of cross-validation is used to ensure that the model is not tested on the same data set on which it was built. The algorithm presented here employs SDA on two different occasions. During iterative motif modification, two steps of SDA are utilized to determine which element of the motif matrix should be modified. At the conclusion, one step of SDA yields a model that provides binding probabilities for each sub-sequence.
The iterative algorithm
The algorithm presented here consists of three stages: alignment, refinement and finalization. The objective of the alignment stage is to determine which sub-sequence of a binding peptide is most likely to be responsible for the binding. To this end, only the positive contribution of residues is considered. That is, if the analysis indicates that a Y in the first position (the variable named Y1) is a significant predictor for separating the two sets, and the coefficient of Yl is positive, then Y1 will be incorporated into the motif matrix. However, if R5 is selected as a significant predictor, but the coefficient of R5 is negative, this information will not be utilized in the alignment stage.
After alignment has been established, the refinement stage allows for the entrance of additional predictors, regardless of the coefficient signs. At this time, the influence of residues which may inhibit binding is incorporated into the motif matrix. The finalization stage expresses the final SDA model in terms of binding probabilities for predictive purposes. Increase the corresponding matrix element by 0.5. Case 2: Coefficient of v 2 is negative:
If the corresponding matrix element is 0, remove v 2 from the list of possible independent variables for the remainder of stage A. If the corresponding matrix element is greater than 0, replace the corresponding matrix element by half its value (e.g. if v 2 = S9, the coefficient of S9 is negative, and w S9 = 1, modify the matrix by setting w S9 = 0.5; or if v 2 = H8, the coefficient of H8 is negative, and w H8 = 0.5, modify the matrix by setting m m = 0.25). This is fine tuning for a previous modification that was too large. 4. With a modified motif matrix, the process is repeated from step 1 until all cases are classified correctly or SDA brings in no new significant variables. Note that all matrix elements will be positive during stage A.
Stage B: Refinement
Repeat the process described in stage A, replacing step 3 with the following step 3'.
3'. Stepwise discriminant analysis output
The motif matrix is modified for the next iteration on the basis of the second variable selected (v 2 ), as follows: 
Stage C: Finalization
The resulting motif matrix is declared the final motif matrix. Using the last database of maximal sub-sequences, one step of SDA is performed, yielding a model with f(r|r 2 r3r4r 5 r 6 r 7 r 8 r9) as the lone predictor. Since this SDA model utilizes only one independent variable (and uniform Bayesian prior probabilities), the probability that a sub-sequence (ss) belongs to the binding set (S B ) can be expressed as: P(ssGS B ) = 1/(1 where and c and /3 are parameters in the SDA model.
A decision rule for classification is constructed by selecting a demarcating probability value. It is common practice to select a value of 0.5. Hence, the decision rule used here will be to classify a sub-sequence as belonging to the binding set when P(ss G S B ) > 0.5.
Since P(ss G S B ) = 0.5 when u = 0, -cl{5 yields the value of f(r 1 r 2 r3r 4 r 5 r 6 r7r 8 r9) that separates binders from nonbinders.
Algorithm illustration
Using the initial motif matrix presented in Table I , the first application of SDA yields f(r 1 r 2 r 3 r4r 5 r 6 r 7 r 8 r9) as the first predictor and L5 with a positive coefficient as the second. Table IV . Predicted alignment of the 37 peptides that bind DR1./ A () = f(r 1 r2r 3 r 4 r 5 r 6 r 7 r 8 r9) at the end of the alignment stage;/ B () = f(r l r 2 r3r 4 r 5 r 6 r 7 r 8 r 9 ) at the end of the refinement stage. P B () = P(ss £ S B ) = the predicted probability that r,r 2 r 3 r,jr5r 6 r 7 r g r 9 binds DRl. Residues in bold have positive entries in the final motif matrix, while underlined residues have negative entries According to the modification rules described in step 3, m L5 is increased to 0.5. The modified motif matrix is shown in Table II . Iteration continues according to the rules of stage A until no remaining independent variable has the necessary significance for model entrance. At this point, the only binder misclassified is B2M 031, while seven of the 98 non-binders (7%) are misclassified. The state of the motif matrix at the end of the alignment stage is presented in columns marked 'A' in Table III. Table IV exhibits the predicted alignment of the 37 DRl binding peptides, along with values for f(r,r 2 r ? r4r 5 r 6 r 7 r 8 r 9 ) denoted by/ A ().
The process continues with the refinement stage where negative influences as well as positive influences are considered. Conclusion is reached when all maximal subsequences, binders and non-binders, are correctly classified.
The final motif matrix is presented in columns marked 'B' in Table III. In the final SDA model, c = -67.82 and j3 = 20.27. Hence, the decision rule used here will state that a value of f(rir 2 r3r 4 r 5 r 6 r7r 8 r9) > 3.35 predicts a DRl binding sequence. Table IV shows for each DRl binding peptide: predicted alignment, the final value for f(r 1 r 2 r3r 4 r5r 6 r 7 r 8 r9) denoted by / B (), and the probability of binding DRl denoted by P B (). For non-binding peptides, the values of/ B () range from 2.0 to 3.25, and the corresponding values of P B () range from 0.00 to 0.13.
Discussion
Alternative models will result from the following variations:
(i) Vary initial motif matrix.
(ii) Vary the number of columns in the motif matrix. (iii) Restrict independent variables to specific columns or specific amino acid residues. (iv) Vary the definition of f(r|r 2 r3r 4 r 5 r 6 r 7 r 8 r9). For example, it is likely that the interaction between neighboring residues is important and should be quantified.
The foregoing example demonstrates that the proposed algorithm does convert a binding motif into a quantitative model with a minimum amount of subjectivity. The character of the initial motif is retained in the final model. It is noteworthy that the core peptide predictions for PCY 088, TTT 830 and HAE 306 agree with the laboratory results of O'Sullivan et al. (1991a) . In addition, the alignment of HAE 306 is consistent with the crystal structure analysis of Stern et al. (1994) . Many of the peptides have more than one subsequence where {{r^T^^Tff^Tg) > 3.35. This supports Kurata and Berzofsky's (1990) suggestion that a given peptide may bind in more than one way. It is clear that the larger the database and the stronger the initial approximation, the more valid the final model.
